You can expect to hear a lot about cancer this week as thousands of oncologists and scientists descend on Chicago for the 2015 American Society of Clinical Oncology (ASCO) annual meeting. ASCO convenes thought leaders from around the world to discuss ways to prevent, treat and cure cancer.
In the last several decades, our scientific understanding of cancer has grown by leaps and bounds. U.S. cancer death rates have fallen 22 percent since 1991, and for many patients, cancer has become a chronic condition to be managed, instead of a death sentence. Still, there is much work to be done to win the war on cancer.
While conversations about the value of cancer medicines often focus on cost, a dollar figure is not the only factor to consider when determining a medicine’s value. Instead, we need to look at how medicines lengthen lives, improve quality of life, and increase productivity, and consider those factors in context with the following five points:
Read More →